Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension

By sjmartinez • October 11, 2022

Didriksen H, Molberg Ø, Mehta A, Jordan S, Palchevskiy V, Fretheim H, Gude E, Ueland T, Brunborg C, Garen T, Midtvedt Ø, Andreassen AK, Lund-Johansen F, Distler O, Belperio J, Hoffmann-Vold AM. Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension. Front Immunol. 2022 Sep 23;13:991743. doi: 10.3389/fimmu.2022.991743. PMID: 36211384; PMCID: PMC9541617.

Tags: Anti-CCL21, CCL21, ELISA Enzyme-linked immunosorbent assay, Luminex (xMAP) method, Publications, pulmonary arteria hypertension, Pulmonary, Critical Care & Sleep Medicine, systemic sclerosis

Managing a Rare Case of Methicillin-Resistant Staphylococcus aureus (MRSA) Holocord With Intravenous Antibiotics

Dao KT, Perera MX, Yip SA, Fox K. Managing a Rare Case of Methicillin-Resistant Staphylococcus aureus (MRSA) Holocord With Intravenous Antibiotics. Cureus. 2025 Mar 2;17(3):e79918.[...]

Injectable Estradiol Dosing Regimens in Transgender and Nonbinary Adults Listed as Male at Birth

Kanin M, Slack M, Patel R, Chen KT, Jackson N, Williams KC, Grock S. Injectable Estradiol Dosing Regimens in Transgender and Nonbinary Adults Listed as[...]

Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial

Bandos H, Kim S, Henry NL, Hays RD, Calsavara VF, Luu M, Gresham G, Lu KY, Irvin WJ, Suga JM, Siddique S, Cecchini RS, Rogatko[...]